CommentLessons for clinical trial design in Friedreich's ataxia
References (10)
- et al.
Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data
Lancet Neurol
(2015) - et al.
Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study
Lancet Neurol
(2016) - et al.
Friedreich's ataxia: clinical features, pathogenesis and management
Br Med Bull
(2017) - et al.
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion
Science
(1996) Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features
Brain
(1981)
There are more references available in the full text version of this article.
Cited by (5)
Artificial intelligence for dementia drug discovery and trials optimization
2023, Alzheimer's and DementiaAllele-specific Effects of Three-dimensional Genome Architecture in Hybrid Pigs
2022, Research SquareDrug Repositioning in Friedreich Ataxia
2022, Frontiers in NeuroscienceTract-Specific Spinal Cord Diffusion Tensor Imaging in Friedreich's Ataxia
2022, Movement DisordersEmerging Therapies in Friedreich’s Ataxia: A Review
2022, touchREVIEWS in Neurology
© 2021 Elsevier Ltd. All rights reserved.